Daily Mail - June 10, 2021
Balazs Halmos, M.D., and Amit Verma, M.B.B.S., comment on their study that finds patients with cancer developed antibodies to COVID-19 after vaccination. Dr. Halmos is director of the Multidisciplinary Thoracic Oncology Program at Montefiore and professor of medicine at Einstein; Dr. Verma is associate director of translational science at the Albert Einstein Cancer Center and director of the division of hemato-oncology at Montefiore.
Dr. Halmos' Profile
The New York Times - June 4, 2021
An Einstein alumna and current Montefiore resident shares her experiences graduating during the height of the pandemic in spring 2020 and starting her career caring for critically ill patients with COVID-19.
The Boston Globe - June 4, 2021
Tia Powell, M.D., explains that a diagnosis of Alzheimer's disease is often accompanied by shame and fear, which can increase the burden on caretakers. Dr. Powell is the Dr. Shoshana Trachtenberg Frackman Faculty Scholar in Biomedical Ethics and director of the Montefiore Einstein Center for Bioethics.
Dr. Powell's ProfileMore coverage on Dr. Powell
Fast Company - June 4, 2021
Maureen Brogan, M.D., discusses rhabdomyolysis, a painful and dangerous syndrome involving muscle overexertion that often results from starting or restarting a rigorous exercise regime. Dr. Brogan is associate professor of medicine at Einstein and a nephrologist at Montefiore.
Dr. Brogan's Profile
Allure - June 1, 2021
Dawn Buse, Ph.D., says people with migraine can still experience fatigue and difficulty concentrating in the postdrome phase of migraine, when most of the other severe headache symptoms have resolved. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.
Dr. Buse's ProfileMore coverage on Dr. Buse
American Heart Association News - May 21, 2021
Jonathan Oxman, M.D., a 2021 graduate of Einstein, describes the research he conducted at the College of Medicine that found a link between perceived discrimination by Hispanic adults and changes in their cardiac structure and function that could lead to cardiovascular disease.
MIT Technology Review - May 13, 2021
Kartik Chandran, Ph.D., explains that despite the existence of variants to COVID-19, the virus has not fundamentally changed, and stresses the importance of using the current effective vaccines to control the pandemic. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.
Dr. Chandran's ProfileMore coverage on Dr. Chandran
Medscape - May 11, 2021
Iman Hassan, M.D., M.S., comments on anti-racist training in medical education using a structural competency framework, which equips physicians with the tools to identify, discuss, and work with patients to address the social, political, and economic structures that affect their health. Dr. Hassan is assistant professor of medicine at Einstein and an internist at Montefiore.
Dr. Hassan's Profile
Medscape - May 7, 2021
Carlos Rodriguez, M.D., M.P.H., and Ayana K. April-Sanders, Ph.D., call for additional studies that will more precisely define metabolically healthy obesity and assist researchers in determining its prevalence. Dr. Rodriguez is professor of medicine and of epidemiology & population health, and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore. Dr. April-Sanders is a postdoctoral fellow in Dr. Rodriguez's lab.
Dr. Rodriguez's Profile
USA Today - May 6, 2021
Jonathan Alpert, M.D., Ph.D., discusses COVID psychosis, a rare condition that may be caused by brain inflammation triggered by the body's immune response to the virus. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
CBS New York - May 6, 2021
Nir Barzilai, M.D., a speaker at the Fifth International Vatican Conference, talks about longevity research aimed at delaying the onset of diseases associated with aging and extending both lifespan and health span. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Genetic Engineering & Biotechnology News - April 23, 2021
Ana Maria Cuervo, M.D., Ph.D., discusses her novel drug that revs up a cellular cleaning process and was found to reverse key symptoms of Alzheimer's disease in mice. Dr. Cuervo is professor of developmental and molecular biology, co-director of the Institute for Aging Research, and holds the Robert and Renée Belfer Chair for the Study of Neurodegenerative Diseases at Einstein.
Additional Coverage includes New Atlas, Fierce Biotech, ANSA, El Nacional, and CBS affiliates
Dr. Cuervo's ProfileMore coverage on Dr. Cuervo
HealthDay - April 20, 2021
Ryan DeLapp, Ph.D., explains there is a growing recognition that exposure to racism can cause symptoms similar to post-traumatic stress disorder in some people. Dr. DeLapp is assistant professor of psychiatry and behavioral sciences at Einstein and an attending psychologist at Montefiore's Child/Adolescent Psychiatric Outpatient Division.
Additional Coverage includes WGBH (interview starts at :35)
Dr. DeLapp's Profile
Bronx Times - April 20, 2021
Third-year medical student Alex Levine describes the Healthy Bronx podcast he and classmates launched last year, which focuses on preventative medicine and transportation. Thirteen episodes have covered a range of issues, including the need for accessible bike paths on Bronx bridges and improved east/west bus service.
UPI - April 19, 2021
David Sharp, Ph.D., discusses a study, co-led with Kelvin Davies, M.Sc., Ph.D., detailing the development of a topical drug that, in rats, regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate cancer. Dr. Sharp is professor of physiology & biophysics and of ophthalmology and visual sciences and professor in the Dominick P. Purpura Department of Neuroscience at Einstein. Dr. Davies is professor of urology and of physiology & biophysics at Einstein.
Dr. Sharp's ProfileMore coverage on Dr. Sharp
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski